Barr Challenges Savient's Oxandrin Patents
Generic drug maker Barr Laboratories Inc. is going after Savient Pharmaceuticals Inc.'s patents covering its lucrative Oxandrin tablets that promote weight gain....To view the full article, register now.
Already a subscriber? Click here to view full article